Search details
1.
Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?
Cell Immunol
; 343: 103753, 2019 09.
Article
in English
| MEDLINE | ID: mdl-29395859
2.
A headlight on liquid biopsies: a challenging tool for breast cancer management.
Tumour Biol
; 37(4): 4263-73, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-26790442
3.
SIUrO best practice recommendations to optimize BRCA 1/2 gene testing from DNA extracted from bone biopsy in mCRPC patients (BRCA Optimal Bone Biopsy Procedure: BOP).
Virchows Arch
; 483(5): 579-589, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37794204
4.
Impact of Different Selection Approaches for Identifying Lynch Syndrome-Related Colorectal Cancer Patients: Unity Is Strength.
Front Oncol
; 12: 827822, 2022.
Article
in English
| MEDLINE | ID: mdl-35223509
5.
The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis.
Ther Adv Med Oncol
; 14: 17588359221110162, 2022.
Article
in English
| MEDLINE | ID: mdl-36188485
6.
Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome.
Front Oncol
; 11: 682445, 2021.
Article
in English
| MEDLINE | ID: mdl-34178674
7.
Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2.
Cancers (Basel)
; 12(9)2020 Aug 25.
Article
in English
| MEDLINE | ID: mdl-32854451
8.
Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)-Prevalence and Geographic Distribution of Pathogenic Variants in BRCA1/2 Genes.
Cancers (Basel)
; 12(5)2020 May 05.
Article
in English
| MEDLINE | ID: mdl-32380732
9.
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype-phenotype correlation in a cohort of 531 patients.
Ther Adv Med Oncol
; 12: 1758835920975326, 2020.
Article
in English
| MEDLINE | ID: mdl-33403015
10.
Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?
Breast Cancer Res Treat
; 113(1): 67-70, 2009 Jan.
Article
in English
| MEDLINE | ID: mdl-18228134
11.
Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1.
J Oncol
; 2019: 5458717, 2019.
Article
in English
| MEDLINE | ID: mdl-31827510
12.
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis.
Cancers (Basel)
; 11(8)2019 Aug 15.
Article
in English
| MEDLINE | ID: mdl-31443300
13.
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients.
Ther Adv Med Oncol
; 11: 1758835919839928, 2019.
Article
in English
| MEDLINE | ID: mdl-31019571
14.
Metastatic Site Location Influences the Diagnostic Accuracy of ctDNA EGFR- Mutation Testing in NSCLC Patients: a Pooled Analysis.
Curr Cancer Drug Targets
; 18(7): 697-705, 2018.
Article
in English
| MEDLINE | ID: mdl-29521235
15.
Universal testing for MSI/MMR status in colorectal and endometrial cancers to identify Lynch syndrome cases: state of the art in Italy and consensus recommendations from the Italian Association for the Study of Familial Gastrointestinal Tumors (A.I.F.E.G.).
Eur J Cancer Prev
; 31(1): 44-49, 2022 01 01.
Article
in English
| MEDLINE | ID: mdl-33767077
16.
"Back to a false normality": new intriguing mechanisms of resistance to PARP inhibitors.
Oncotarget
; 8(14): 23891-23904, 2017 Apr 04.
Article
in English
| MEDLINE | ID: mdl-28055979
17.
Absence of germline CDKN2A mutation in Sicilian patients with familial malignant melanoma: Could it be a population-specific genetic signature?
Cancer Biol Ther
; 17(1): 83-90, 2016.
Article
in English
| MEDLINE | ID: mdl-26650572
18.
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus.
Oncotarget
; 7(30): 47821-47830, 2016 Jul 26.
Article
in English
| MEDLINE | ID: mdl-27374102
19.
Prognostic and predictive biomarkers for targeted therapy in NSCLC: for whom the bell tolls?
Expert Opin Biol Ther
; 15(11): 1553-66, 2015.
Article
in English
| MEDLINE | ID: mdl-26360115
20.
Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option?
Anal Cell Pathol (Amst)
; 2015: 690916, 2015.
Article
in English
| MEDLINE | ID: mdl-26484003